Russ Altman

What really happens when you mix medications?

Share This Talk

TEDMED Talks are available, free to the world, thanks to our partners.

About Russ Altman

Professor of Bioengineering, Genetics, Medicine and Computer Science at Stanford University, Russ Altman’s primary research interests are in the application of computing and informatics technologies to problems relevant to medicine. He is particularly interested in methods for understanding drug actions at molecular, cellular, organism and population levels, including how genetic variation impacts drug response. Altman received the U.S. Presidential Early Career Award for Scientists and Engineers, a National Science Foundation CAREER Award and Stanford Medical School's graduate teaching award. He has chaired the Science Board advising the FDA Commissioner, and currently serves on the NIH Director’s Advisory Committee. He is a clinically active internist, the founder of the PharmGKB knowledgebase, and advisor to pharmacogenomics companies.

Find out more

About This Talk

Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.

Other Talks from TEDMED 2015